WE WANT TO MAKE PERSONALIZED MEDICINE A REALITY FOR India and South Asia
After a successful pilot study with valuable contributions from early adopters in USA, YouGenomics is now coming to India as Genvali Biotech Private Limited. We learned a lot from the pilot YouGenomics India Project and want to bring this science and breakthrough technology to everyone in India (and rest of South Asia in the near future). Stay tuned for more information.
South Asian countries have been vastly under-represented in large-scale genetic studies. Genavli is committed to fix this. To make this happen, we are offering state-of-the-art ultra-low coverage whole-genome DNA sequencing test at a nominal cost to USA residents from Bangladesh, India, Nepal, Pakistan and Sri Lanka. The data will be used to build the reference genotype profile for the South Asian population. This reference data will be the first step towards understanding the genetic defects underlying diseases affecting these populations and also designing South Asia focused genetic tests for earlier diagnosis. We believe that the success of Genavli Biotech will shape the future of medicine in South Asia.
Founder and Scientific Advisor
Avinash has over two decades of experience in the fields of medicine, bioinformatics and human genetics. After completing MD in India, Avinash pursued advanced education in bioinformatics and human genetics in Sweden. His post-doctoral work at Rockefeller University, New York focused on using next-generation sequencing techniques to unravel genetic defects underlying susceptibility to various infectious diseases. During his career he has made major contributions to the understanding of genetics of complex disorders like type 2 diabetes to rare monogenic forms of severe pediatric disorders. Avinash also leads the Clinical Informatics group at the New York Genome Center, New York focusing on translating high-throughput sequencing data to personalized therapies for human cancers and undiagnosed diseases. For more information about Avinash's contribution to science check his Google Scholar profile.